Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,324,192 | 1,330,813 | 1,700,088 | 230,064 | 1,241,201 |
| Depreciation Amortization | 32,489 | 19,562 | 20,499 | 27,026 | 43,158 |
| Accounts receivable | -2,360 | -4,551 | -1,521 | -4,744 | -29,143 |
| Other Working Capital | 1,076,447 | 887,371 | 1,009,038 | 414,802 | 234,449 |
| Other Operating Activity | 59,055 | 535,791 | 259,698 | 1,476,832 | 527,871 |
| Operating Cash Flow | $2,489,823 | $2,768,986 | $2,987,802 | $2,143,980 | $2,017,536 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,697,729 | -2,505,701 | -2,115,522 | -1,741,640 | -2,191,502 |
| PPE Investments | N/A | -18,000 | N/A | -21,215 | N/A |
| Net Acquisitions | -74,416 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -504,740 | -298,455 | -24,942 | -812,109 | -1,455,609 |
| Sale Of Investment | 671,651 | 142,002 | 69,713 | 1,545,543 | 1,776,831 |
| Other Investing Activity | -8,946 | 2,039 | -2,038 | 0 | 0 |
| Investing Cash Flow | $-1,614,180 | $-2,678,115 | $-2,072,789 | $-1,029,421 | $-1,870,280 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,275,000 | N/A | 350,000 | N/A | N/A |
| Debt Issued | 1,954,475 | 1,471,235 | N/A | N/A | 1,272,533 |
| Debt Repayment | -1,000,000 | N/A | -1,000,000 | N/A | N/A |
| Common Stock Issued | 5,917 | 5,107 | 7,476 | 7,192 | 44,213 |
| Common Stock Repurchased | -1,227,383 | -229,651 | -304,759 | N/A | N/A |
| Dividend Paid | -900,629 | -863,904 | -854,848 | -950,701 | -918,588 |
| Other Financing Activity | -1,293,353 | -21,642 | -346,623 | -1,347 | -13,046 |
| Financing Cash Flow | $-1,185,973 | $361,145 | $-2,148,754 | $-944,856 | $385,112 |
| Beginning Cash Position | 929,026 | 477,010 | 1,710,751 | 1,541,048 | 1,008,680 |
| End Cash Position | 618,696 | 929,026 | 477,010 | 1,710,751 | 1,541,048 |
| Net Cash Flow | $-310,330 | $452,016 | $-1,233,741 | $169,703 | $532,368 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,489,823 | 2,768,986 | 2,987,802 | 2,143,980 | 2,017,536 |
| Capital Expenditure | N/A | -18,000 | N/A | -21,215 | N/A |
| Free Cash Flow | 2,489,823 | 2,750,986 | 2,987,802 | 2,122,765 | 2,017,536 |